The Cleveland ADRC in the News

Researchers discover new way to monitor & prevent nerve cell deterioration after TBI – EurekaAlert by the American Association for the Advancement of Science

“In a new study, published online today in Cell, researchers have discovered a new way to prevent brain nerve cells from deteriorating after injury, which also revealed a potential mechanistic link between TBI and AD…The findings from the Pieper lab represent an outgrowth of collaborative efforts from investigators across the Cleveland community at UH, HDI, Case Western Reserve, VA Northeast Ohio Healthcare System, Cleveland Clinic and The MetroHealth System.”

 

New Alzheimer’s disease pathway discovered, providing earlier target for potential therapies – The Daily

“The new discoveries were also facilitated by the Translational Therapeutics Core of the Cleveland Alzheimer’s Disease Research Center…”

 

Alzheimer’s Association working to identify, care for veterans at risk for dementia – cleveland.com

“In September, the Cleveland Alzheimer’s Disease Research Center received a grant from the National Institute on Aging to enroll veterans with early Alzheimer’s and mild cognitive impairment in dementia research.”

Cleveland Clinic-UH collaboration expanding beyond COVID-19: Tom Mihaljevic and Cliff A. Megerian – cleveland.com

“Among successful current collaborations are the Case Comprehensive Cancer Center, the Cleveland Alzheimer’s Disease Research Center and the Clinical and Translational Science Collaborative of Cleveland, which are achieved in cooperation with Case Western Reserve University School of Medicine.”

Addressing Alzheimer’s – The Review Times

“Dr. Alan Lerner, who is co-director of the Clinical Core at the Cleveland Alzheimer’s Disease Research Center and director of the Brain Health and Memory Center at the Neurological Institute of University Hospitals Cleveland Medical Center, said early detection is critical to beating Alzheimer’s.”

Ohio emerges as major model of collaboration in Alzheimer’s research – Richland Source

“Today, “I’d say (Ohio) is square in the middle of the pack. The Cleveland Alzheimer’s Disease Research Center (CADRC) is a huge national acknowledgment of the progress,” said Lerner, who is co-director of the Clinical Core at the Alzheimer’s Disease Research Center…”

Cleveland health institutions receive $4.2 million for Alzheimer’s research center – Cleveland.com

“Thanks to a $4.23 million grant from the National Institutes of Health, Cleveland is about to become a national hub for research into Alzheimer’s and related diseases.”

Cleveland to establish collaborative research center for Alzheimer’s disease with $4 million grant – Crains Cleveland

“Cleveland will be home to a new collaborative research center focused on Alzheimer’s disease.
A two-year, $4.23 million grant from the National Institute on Aging of the National Institutes of Health will establish the Cleveland Alzheimer’s Disease Research Center.”

Cleveland Alzheimer’s Disease Research Center to be established following multi-million dollar grant – 19 News

“The Cleveland Alzheimer’s Disease Research Center will be the first NIH-funded Alzheimer’s research center in Ohio. It will join the 30 other NIH-funded Alzheimer’s Disease Research Centers of Excellence in the U.S.”

Cleveland at forefront of Alzheimer’s disease research – Cleveland.com

“‘Now, Cleveland is one of the 31 Alzheimer’s Disease Research Centers located around the country. This brings resources for investigators to collaborate and team up to tackle some of the hard questions, or to develop technologies,’ Hill said.”

Cleveland Alzheimer’s Disease Research Center on The Sound of Ideas – WCPN Ideastream
(CADRC part starts at 15:00)

“This region is about to become a central player in the search to find new drugs, new methods, and new ideas, in the fight against Alzheimer’s Disease. It’s spearheaded by a consortium of area health institutions and funded by a $4 million grant from the National Institutes of Health. We talk with doctors and administrators of the new Cleveland Alzheimer’s Disease Research Center.”